The Drug Case Machine: How Narcotics Charges Sustain the American Court System

What the Docket Actually Looks Like

In fiscal year 2025, the U.S. Sentencing Commission processed 66,662 cases. Of those, 16,234 involved drug offenses and 16,144 specifically involved drug trafficking. That is roughly one in four cases in the entire federal sentencing pipeline. The Administrative Office of the U.S. Courts places drug offenses at 26 percent of all federal criminal defendant filings for the year ending March 31, 2024.

Alongside immigration, firearms, and fraud, drugs have formed the backbone of the federal criminal docket for more than 25 years. That pattern, noted in the U.S. Sentencing Commission’s 2024 Annual Report, has not meaningfully shifted regardless of which party controls Congress or the White House. The cases keep coming because the legal and budgetary infrastructure built around them requires that they do.

State courts carry a proportionally similar load, though the data is less standardized. The National Center for State Courts found that criminal cases represented 23 percent of total state court caseloads in 2024, with drug offenses constituting a substantial share of felony filings in virtually every jurisdiction. In Michigan, felony cases are categorized into six statutory groups; crimes involving a controlled substance constitute one of those six primary classification tracks, placing drug cases alongside crimes against persons and crimes against property as a foundational pillar of felony court administration.

The Revenue Side of the Equation

Courts do not merely process drug cases. They extract revenue from them at every stage of the criminal process.

Civil asset forfeiture, the mechanism by which law enforcement can seize property connected to alleged criminal activity before a conviction, is heavily concentrated in drug enforcement. The DOJ forfeiture fund and the Treasury forfeiture fund together held an estimated $5.3 billion in net assets in fiscal year 2024, according to data compiled by the Prison Policy Initiative. Drug investigations generate the majority of federal forfeiture activity by volume.

Below forfeiture, court systems extract fines and fees from drug defendants at rates that exceed those imposed on other offense categories. A 2009 analysis found that 36 percent of all non-incarcerated drug offenders were fined, a rate substantially higher than that applied to property crime defendants. Court costs, supervision fees, drug testing fees, and program fees attach to drug cases through every phase of pretrial release, probation, and post-incarceration supervision.

Local governments collectively reported approximately $9 billion in fines and forfeiture revenue in 2020. The Fines and Fees Justice Center and academic researchers have documented that jurisdictions with higher dependence on this revenue are measurably less likely to clear violent crime cases, because enforcement energy follows the revenue, not the public safety priority.

The DEA’s Fentanyl Walk-Through Problem

An Associated Press investigation published in June 2026 documented DEA operations in New Mexico between 2023 and 2025 in which agents monitored fentanyl shipments but chose not to seize them in order to build larger trafficking prosecutions. Three current and former DEA agents provided accounts to AP, along with government records reviewed by the outlet.

Howell, who filed a formal whistleblower complaint in 2023, alleged that agents allowed at least 1.8 million fentanyl pills to go unseized during a single multi-state investigation. A former DEA supervisor, speaking anonymously, told AP the investigation allowed “millions” of pills to reach the streets before a culminating bust, announced in May 2025 by then-Attorney General Pam Bondi, that the DEA described as the largest fentanyl seizure in its history.

The operative logic, as documented by AP, was that larger organizations produce larger cases, larger cases produce larger seizures, and larger seizures produce the statistical and political outcomes that justify the DEA’s budget and institutional posture. The former supervisor told AP that the organization could have been dismantled six months earlier. The additional months served the case record, not the communities absorbing the supply.

The DEA disputed Howell’s characterization in a statement to AP, describing the investigative decisions as lawful, reasonable, and consistent with department guidance. The Justice Department’s Office of Professional Responsibility reviewed the matter in 2024 and found no “specific danger to public health” in the approach taken. Howell was moved to desk duty for more than a year after coming forward and was barred from testifying in federal court.

New Mexico’s fentanyl death data complicates the institutional response. While overdose deaths fell 14 percent nationally in the most recent reporting period, New Mexico recorded a 21 percent increase. Albuquerque, the primary theater of the operations Howell described, has a neighborhood known locally as “War Zone” for the density of drug activity. The gap between national trend and local outcome is not attributed to any single cause, but the AP reporting raises the question directly.

The Incentive Structure This Reveals

The DEA’s decision framework, as described by AP sources, is not an aberration. It is a logical product of the enforcement economy that drug prosecution has built. Large cases produce large seizures. Large seizures produce forfeiture revenue and institutional prestige. Institutional prestige justifies budget requests. Budget requests get funded when the caseload statistics support them.

This dynamic operates across the system. Prosecutors in offices that handle predominantly drug dockets develop institutional expertise, staffing structures, and performance metrics calibrated to narcotics volume. The career offender guideline, which applies to a small share of federal drug defendants but generates some of the longest sentences in the system, creates high-profile outcomes that support enforcement narratives. Mandatory minimum penalties, which attached to 56 percent of federal drug trafficking defendants in fiscal year 2025, reduce the complexity of disposition while keeping cases moving through the pipeline at scale.

The communities absorbing the cost of that system are not abstract. New Mexico’s overdose numbers are not a policy variable. Nor are the families in Michigan, in Kalamazoo County, in Barry County, in Genesee County, in any of the jurisdictions where drug enforcement generates the caseload that fills courts, funds prosecutors, and sustains the institutional machinery of criminal adjudication. The system’s appetite for drug cases is not incidental to the communities it processes. It is the mechanism through which those communities are processed.

What a Reduced Drug Docket Would Actually Mean

Federal drug filings at 26 percent of the criminal docket represent the floor, not the ceiling, of the system’s dependence on narcotics enforcement. Below the federal level, state courts handle misdemeanor drug possession, civil infractions tied to drug paraphernalia, drug court program caseloads, and probation revocations driven by substance use. Each of those categories carries its own administrative load, fee structure, and judicial resource demand.

A contraction of drug enforcement, whether through decriminalization, diversion, or reduced prosecutorial priority, would not simply remove cases from a docket. It would remove the revenue basis for multiple institutional functions simultaneously: forfeiture funds that offset law enforcement budgets, fines and fees that partially offset court operating costs, supervision populations that justify probation officer headcount, and prosecution caseloads that justify DA office staffing levels.

The system does not have a neutral posture toward drug enforcement. It has a financial dependency on it. The DEA’s calculated decision to let fentanyl move in order to make cases is that dependency made visible at the operational level. The bigger fish argument, as the former U.S. attorney in Albuquerque framed it, is not wrong on its own terms. But it is only persuasive if the goal is cases. If the goal is the absence of fentanyl in the community, the calculation looks different.